Acute Myeloid Leukemia Clinical Trials

A listing of Acute Myeloid Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

UPDATED

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study of ABBV-075

UPDATED

Tucson Arizona 85724

A clinical research study for the treatment of Acute Myeloid Leukemia

UPDATED

Tucson Arizona 85719

A clinical research study for the treatment of Acute Myeloid Leukemia

Connecticut

UPDATED

New Haven Connecticut 06520

Patients are needed to participate in a clinical research study of ABBV-075

Florida

UPDATED

Jacksonville Florida 32204

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

UPDATED

Tampa Florida 33612

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Georgia

UPDATED

Atlanta Georgia 30322

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Atlanta Georgia 30322

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Atlanta Georgia 30322

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Atlanta Georgia 30322

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Illinois

UPDATED

Chicago Illinois 60637

A clinical research study for the treatment of Acute Myeloid Leukemia

UPDATED

Chicago Illinois 60637

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Chicago Illinois 60637

Patients are needed to participate in a clinical research study of ABBV-075

Indiana

UPDATED

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study of ABBV-075

Kansas

UPDATED

Fairway Kansas 66205

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Fairway Kansas 66205-2528

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Kansas City Kansas 66160

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Westwood Kansas 66205

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Westwood Kansas 66205

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

View More ▼

UPDATED

Westwood Kansas 66205

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Maryland

UPDATED

Baltimore Maryland 21287

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Massachusetts

UPDATED

Boston Massachusetts 02114

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Boston Massachusetts 02115

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Boston Massachusetts 02215

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Michigan

UPDATED

Ann Arbor Michigan 48109-2800

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Ann Arbor Michigan 48109

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

New York

UPDATED

Buffalo New York 14263

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

New York New York 10016

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

UPDATED

New York New York 10032

Patients are needed to participate in a clinical research study of PLX51107 to evaluate Solid Tumors, Acute Myeloid Leukemia or Myelodysplastic Syndrome

North Carolina

UPDATED

Winston-Salem North Carolina 27157

A clinical research study for the treatment of Acute Myeloid Leukemia

Ohio

UPDATED

Canton Ohio 44718

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

UPDATED

Cleveland Ohio 44195

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Columbus Ohio 43210

Patients are needed to participate in a clinical research study of PLX51107 to evaluate Solid Tumors, Acute Myeloid Leukemia or Myelodysplastic Syndrome

Oregon

UPDATED

Portland Oregon 97239

A clinical trial to evaluate treatments using BPX-701 and Rimiducid for patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Pennsylvania

UPDATED

Philadelphia Pennsylvania 19107

Patients are needed to participate in a clinical research study of PLX51107 to evaluate Solid Tumors, Acute Myeloid Leukemia or Myelodysplastic Syndrome

South Carolina

UPDATED

Charleston South Carolina 29425

Patients are needed to participate in a clinical research study of PLX51107 to evaluate Solid Tumors, Acute Myeloid Leukemia or Myelodysplastic Syndrome

Tennessee

UPDATED

Knoxville Tennessee 37920

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Nashville Tennessee 37203

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Nashville Tennessee 37203

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Nashville Tennessee 37203

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Texas

UPDATED

Dallas Texas 75230

Patients are needed to participate in a clinical research study of ABBV-075

UPDATED

Houston Texas 77030

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Houston Texas 77030

Patients are needed to participate in a clinical research study of ABBV-075

UPDATED

San Antonio Texas 78229

Patients are needed to participate in a clinical research study of PLX51107 to evaluate Solid Tumors, Acute Myeloid Leukemia or Myelodysplastic Syndrome

Virginia

UPDATED

Arlington Virginia 22031

Patients are needed to participate in a clinical research study of ASP2215 and Placebo to evaluate Acute Myeloid Leukemia (AML) or Acute Myeloid Leukemia With FMS-like Tyrosine Kinase (FLT3) / Internal Tandem Duplication (ITD) Mutation

Washington

UPDATED

Seattle Washington 98195

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

UPDATED

Seattle Washington 98109

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Japan

UPDATED

Akita 010-8543

Patients are needed to participate in a clinical research study to evaluate Acute Myeloid Leukemia

UPDATED

Chuo-ku Tokyo 104-0045

Patients are needed to participate in a clinical research study to evaluate Acute Myeloid Leukemia

UPDATED

Fukuoka 812-8582

Patients are needed to participate in a clinical research study to evaluate Acute Myeloid Leukemia